Related Experiment Videos
Inflammation and the Long-Term Incidence of Hypertension in Women
Nicholas H Adamstein1,2, M Vinayaga Moorthy2, Nancy R Cook2,3
1Division of Cardiovascular Medicine, Heart and Vascular Institute, Mass General Brigham, Boston, MA.
Insights
Chronic inflammation, measured by high-sensitivity C-reactive protein (hsCRP), independently predicts hypertension in women long-term. However, its predictive value diminishes after 20 years.
Area of Science:
- Cardiovascular Health
- Inflammation Research
- Women's Health
Background:
- Chronic inflammation is linked to hypertension development.
- High-sensitivity C-reactive protein (hsCRP) is a marker of low-grade inflammation.
- Understanding inflammation's role in hypertension is crucial for women's cardiovascular health.
Purpose of the Study:
- To investigate the independent association between baseline hsCRP levels and incident hypertension over three decades in women.
- To determine if hsCRP is a long-term predictor of hypertension in a female cohort.
Main Methods:
- Utilized data from the Normotensive Women's Health Study, following 20,224 women for up to 30.9 years.
- Employed cause-specific Cox proportional hazards models, adjusting for numerous covariates.
- Conducted landmark analyses to assess hsCRP's predictive value over different time intervals (decades).
Main Results:
- Over 70% of women developed hypertension during follow-up.
- Higher baseline hsCRP levels were significantly associated with increased risk of incident hypertension (HR 1.33 comparing extreme quintiles).
- The association between hsCRP and hypertension was significant for the first two decades but waned thereafter.
Conclusions:
- A single hsCRP measurement independently predicts incident hypertension in women in the near to intermediate term.
- Inflammation may represent a primordial risk factor for hypertension in women.
- The prognostic value of hsCRP for hypertension is limited beyond 20 years of follow-up.
Aims:
Chronic inflammation associates with prevalent and short-term incident hypertension. The aim of this study is to determine whether baseline high-sensitivity C-reactive protein (hsCRP) independently associates with incident hypertension over three decades in women.
Methods:
Normotensive Women's Health Study participants with a baseline hsCRP measurement were followed for incident hypertension for up to 30.9 years. Cause-specific Cox proportional hazards models estimated hazard ratios for incident hypertension across hsCRP quintiles and per SD log(hsCRP). Models were adjusted for a minimally sufficient set of covariates derived from a directed acyclic graph, including age, study arm, BMI, smoking, exercise, dietary factors, alcohol use, eGFR, and hormone replacement therapy (HRT). Stratified analyses were performed across categories of age, SBP, DBP, BMI, and HRT use. Landmark analyses estimated separate hazard ratios for each decade.
Results:
14,234 of 20,224 (70%) women developed hypertension during follow-up. Baseline hsCRP was associated with time-to-incident hypertension, with a time-averaged multivariable hazard ratio of 1.33 (95% CI 1.25-1.41) comparing the top and bottom quintiles, and 1.10 (95% CI 1.08-1.12) per SD log(hsCRP). There was no effect modification by age, SBP, DBP, BMI, or HRT use. In landmark analyses, hsCRP was associated with incident hypertension in the first two decades, but not beyond 20 years.
Conclusions:
A single measure of low-grade inflammation independently associated with time-to-incident hypertension over the near- to intermediate-term, with limited prognostic value beyond 20 years. These data suggest that inflammation may be a primordial risk factor for hypertension in women.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hormonal Regulation
Hypertension I: Introduction